New Products Boost TTP Labtech’s Sales

MELBOURN, England

TTP Labtech, a world leader in the design and development of automated instrumentation and consumables for life science applications, today reported record orders of £20.1 million for the year ending 31^st March 2015.

Growth has been driven by the latest products, dragonfly^® and arktic^®, both of which have seen significant market uptake.

Market response to dragonfly, a liquid handler for simple, fast and accurate crystal screen optimisation, has been extremely positive and has led to interest across a range of additional application areas including high throughput assay development and rapid low volume reagent dispensing.

Adoption of TTP Labtech’s arktic has accelerated within the biological sample management market and is fast becoming the preferred choice for automated, high-density -80 ^oC storage. As more laboratories standardise the storage of their biospecimen collections to protect sample integrity, automated stores become critical, not just for the pharma and biotech industry but also in smaller academic settings. arktic’s modular format provides scalability, making it an attractive investment for laboratories of all sizes.

On the back of significantly higher sales orders, revenue has also increased by 7.5% to £18.7 million, demonstrating strong performance across TTP Labtech’s liquid handling, imaging and sample storage product ranges. In addition the positive market uptake of arktic has resulted in a strong order book coming into this financial year.

During the year TTP Labtech further strengthened its global reach adding new distributors in Singapore, Taiwan and Qatar. In addition a new office has been opened in Delhi to provide local sales and support for an increasingly important Indian market.

“As well as maintaining our commitment to excellent customer and applications support for our existing product lines, we are driven by the desire to bring new innovative products to market. Close customer relationships and ongoing collaborations are key to our R&D success and ongoing growth. The potential of this approach is demonstrated by the number of new products we have in development, some of which will be launched in 2016/2017, making for a very exciting year ahead,” commented David Newble, newly appointed managing director of TTP Labtech.

Notes to the editors:

About TTP Labtech – natural innovators

From its global headquarters based near Cambridge, UK, TTP Labtech creates, designs and manufactures robust and innovative automated laboratory equipment and consumables for both the academic and industrial sectors of pharmaceutical and biotech research.

TTP Labtech is part of TTP Group plc, an employee owned company that originated from The Technology Partnership (TTP) which is Europe’s leading independent centre for innovation. For 14 years TTP Labtech has successfully combined cutting edge science with first rate engineering. Innovation is at the core of the company and is illustrated by the passion and expertise of its personnel and evidenced by the novel products and technologies that are brought to market.

TTP Labtech provides state-of-the-art solutions developed for specific product areas: cell-based screening (acumen Cellista^®, mirrorball^®); sample management (comPOUND^®, arktic^®, lab2lab) and low volume liquid handling (mosquito^®, dragonfly^®).

For further information please visit www.ttplabtech.com.

View source version on businesswire.com: http://www.businesswire.com/news/home/20150701005649/en/

Enquiries
TTP Labtech
Sarah Burl
Tel: +44 (0)1763 262626
Email: sarah.burl@ttplabtech.com
Twitter: @ttplabtech
or
Media enquiries
BioStrata
Clare Russell
Tel: +44(0)1223 828 200
Email: crussell@biostratamarketing.com